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Received September 28, 2014; accepted January 12, 2015AbstractBackground: The influence of b-blockers on heart rate recovery (HRR) and rating of perceived exertion (RPE) during Phase I cardiac reha-
bilitation (CR) for patients with a recent episode of acute myocardial infarction (AMI) is not clear.
Methods: From October 2009 to July 2011, 105 patients with a recent episode of AMI who received a successful percutaneous coronary
intervention were recruited into this study. Before entering Phase II CR, each patient underwent a cardiopulmonary exercise test (CPET), where
RPE was assessed every minute and related parameters were recorded.
Results: The participants entering CR had relatively low mean peak oxygen consumption (VO2max). However, the peak heart rate and VO2max
were lower in those taking b-blockers. The RPE value at the ventilatory threshold (VT) was significantly higher (12.7 ± 1.7) in participants who
were taking b-blockers relative to those who were not (11.5 ± 1.4). The HRR value was lower (12.5 ± 8.8) in participants who were taking b-
blockers relative to those who were not (17.0 ± 9.1).
Conclusion: These findings suggest that use of b-blockers increased the RPE value at the VT. In addition, HRR was attenuated by b-blockers. In
patients who do not undergo CPET, the use of b-blockers should be taken into consideration when using RPE for the initial exercise prescription
to determine training intensity.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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and cardiovascular mortality rates as well as risk factorsConflicts of interest: The authors declare that there are no conflicts of interest
related to the subject matter or materials discussed in this article.
* Corresponding author. Dr. Sen-Wei Tsai, Department of Physical Medicine
and Rehabilitation, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical
Foundation, 66, Section 1, Fengxing Road, Taichung 427, Taiwan, ROC.
E-mail address: tsaisenwei@gmail.com (S.-W. Tsai).
http://dx.doi.org/10.1016/j.jcma.2015.05.009
1726-4901/Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Assassociated with myocardial infarction. It also provides im-
provements in heart rate recovery (HRR), health-related quality
of life, and exercise capacity.1e4 The symptom-limited or
maximal cardiopulmonary exercise test (CPET) is customarily
considered the gold standard to determine the ventilatory
threshold (VT), peak oxygen consumption (VO2max), and peak
heart rate (HRpeak). To more effectively improve aerobic ca-
pacity or VO2max, several initial training intensities were sug-
gested as follows: (1) training at or just above the lactate
threshold or VT, (2) training initially at 50% of VO2max, or (3)
training at 40e80% of the maximal heart rate using the heartociation. All rights reserved.
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the CPET results.5 Patients with an acute myocardial infarction
(AMI) are candidates for entering aCR program.6 Becausemost
patients with an AMI receive b-blocker therapy, the use of heart
rate to monitor or guide exercise may not be applicable in
clinical practice due to the attenuation of the heart rate caused
by the b-blockers themselves.7,8 Other methods, such as rating
of perceived exertion (RPE), may be necessary alternatives for
monitoring exercise progression or termination.
The 6e20 Borg RPE Scale is a reliable and commonly used
tool for assessing perceived effort during exercise.9e12 The
relationships between the RPE and exercise physiological
markers, such as the VT and oxygen uptake (VO2), are
markedly strong in healthy people.11,13,14 Although the RPE is
a valuable and reliable indicator of exercise tolerance in
healthy people, only limited data focusing on the relationships
between the RPE and other indicators of the CPET exist;
furthermore, the effect of b-blockers on this association in
post-AMI patients has not been clearly demonstrated.15e17
HRR, defined as the difference from HRpeak to HR
measured at 1 minute after peak exercise, is associated with
mortality in cardiovascular disease.18 However, little is known
about the effects of b-blockers on the HRR of patients with a
recent episode of AMI.19
Patients with a recent episode of AMI who were entering a
CR program were enrolled in this study. The aim of this study
was to determine whether b-blockers affected the RPE value
close to the VT, to disclose the effect of b-blockers on HRR,
and other variables obtained during the CPET.
2. Methods2.1. ParticipantsFrom October 2009 to July 2011, patients with AMI at Tai-
chung Veterans General Hospital, Taichung, Taiwan who
received a successful percutaneous coronary intervention and
completed a Phase I CR program were selected for recruitment
into this study. Before discharge, the benefits of exercise were
explained by physical therapists, and the patients were
encouraged to participate in Phase II of the CR program. Data
were excluded if neurological or musculoskeletal disorders
were evident, if participants failed to complete the CPET pro-
cedure, or if exercise termination was due to clinical criteria for
an absolute stop as outlined by the American College of Sports
Medicine (e.g., chest tightness or S-T depression on an elec-
trocardiogram during the CPET).5 In total, 113 patients were
recruited, of whom 105 completed the CPET and were thus
included in the analysis. Informed consents were obtained from
the recruited participants before their study entry. The study
protocol was approved by the Ethics Committee for Human
Research of Taichung Veterans General Hospital.2.2. RPE ScaleBefore undergoing the exercise test, the Borg 6e20 RPE
Scale was explained to the participants so they could correctlyreport their overall feelings of exertion. The participants were
asked to provide their subjective RPE by pointing to a number
during the last 5 seconds of each minute of the CPET from the
resting phase to the recovery phase. The RPE recorded at the
end of the exercise session was defined as the maximal RPE.
After the VT had been determined by the V-slope method, the
RPE values associated with the VT (VT RPE) and the asso-
ciated workload (VT workload) were defined according to the
time of VT.2.3. Exercise testing protocolThe procedures were fully explained to all participants
before the test. They were continuously monitored using a 12-
lead electrocardiogram and a blood pressure gauge while in an
upright position throughout the exercise testing period. The
participants exercised using a MasterScreen CPX (CareFusion
Respiratory Care, San Diego, CA, USA) with a cycle
ergometer according to the procedure described in a previous
report.20 In brief, after a 3-minute rest period, the participants
initially cycled for 3 minutes at 10 W for the baseline warm-
up. Subsequently, the exercise load was increased at in-
crements of 10 W/min. The pedal rate was set at 60 revolu-
tions/min during the whole CPET period. The participants
were encouraged to continue exercising until exhaustion or
until achieving the following criteria: (1) RPE > 17, (2) res-
piratory exchange ratio (RER) > 1.10, (3) plateau in VO2
despite increasing workload, and (4) >85 age-predicted
maximal HR. After the peak exercise period, the participants
were required to undergo a 3-minute cool-down phase at 10 W.
The parameters such as resting HR, HRpeak, maximal oxygen
consumption (VO2max mL/min/kg), and differences between
HRpeak and resting HR (HRpeakerest) were measured. At the
time point of exactly 1 minute into the recovery phase, HRR
was collected.2.4. Statistical analysisThe Chi-square and Student t tests were used to compare
the basic characteristics and proportions between participants
with or without b-blockers. Multiple lineal regression analysis
was used to analyze the influence of different factors and
variables on VT RPE. Pearson correlation coefficient was used
to compare the association between variants. The data are
presented as mean ± standard deviation. Analyses were per-
formed using SPSS (version 13.0; SPSS Inc., Chicago, IL,
USA). The differences were considered statistically significant
when p < 0.05.
3. Results3.1. Descriptive statistics of the participants and RPE
measured during the exercise testsThe participants' characteristics, including age, sex, medi-
cal history, and medication (b-blockers) use, are summarized
in Table 1. Among these 105 participants, the VT could be
Table 1
Baseline clinical and demographic characteristics of the study participants.
b-blocker
(n ¼ 52)
No b-blocker
(n ¼ 42)
p
Variable
Age (y) 58.2 ± 12.3 57.6 ± 10.0 0.81
Male 46 37 0.96
Smoking 9 10 0.44
Diabetes mellitus 6 6 0.70
Hypertension 33 21 0.19
Calcium channel blocker 12 11 0.80
ACEI/ARB 31 28 0.50
Antiplatelet 44 35 >0.99
Nitrate 24 15 0.40
Hyperlipidemia 32 24 0.58
NYHA classification 0.08
NYHA Class 1 6 7
NYHA Class 2 21 23
NYHA Class 3 21 11
NYHA Class 4 5 0
BMI (kg/m2) 25.4 ± 3.0 25.1 ± 2.8 0.69
LVEF (%) 47.2 ± 10.5 50.1 ± 7.8 0.16
Data are presented as n or mean ± SD, unless otherwise indicated.
ACEI/ARB ¼ angiotensin-converting enzyme inhibitor/angiotensin receptor
blocker; BMI ¼ body mass index; LVEF ¼ left ventricular ejection fraction;
NYHA ¼ New York Heart Association.
Table 2
Estimated VT RPE modeling results for selected independent factors by
multiple linear regression analysis.
Parameter Estimate Standard error p
Intercept 8.40 3.11 0.01*
b-blockers 1.399 0.38 <0.001**
BMI (kg/m2) 0.15 0.07 0.04*
Age (y) 0.003 0.02 0.88
Sex (male) 0.69 0.61 0.27
LVEF (%) 0.01 0.02 0.79
Diabetes mellitus 0.63 0.60 0.29
Hypertension 0.10 0.42 0.82
Hyperlipidemia 0.47 0.38 0.22
Smoking 0.27 0.48 0.58
Calcium channel blocker 0.55 0.39 0.16
ACEI/ARB 0.39 0.40 0.33
Antiplatelets 0.31 0.46 0.51
Nitrate 0.11 0.36 0.77
Resting HR (bpm) 0.01 0.02 0.48
NYHA classification 0.17 0.28 0.54
Data are presented after adjustment for age, ACEI/ARB, antiplatelets, BMI,
calcium channel blocker, diabetes mellitus, sex, hypertension, hyperlipidemia,
LVEF, NYHA classification, resting HR, and smoking.
*p < 0.05.
**p < 0.01.
ACEI/ARB ¼ angiotensin-converting enzyme inhibitor/angiotensin receptor
blocker; BMI ¼ body mass index; bpm ¼ beats/min; HR ¼ heart rate;
LVEF ¼ left ventricular ejection fraction; NYHA ¼ New York Heart Asso-
ciation; RPE ¼ rating of perceived exertion; VT ¼ ventilatory threshold.
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participants). These 94 participants were selected for the
analysis of VT RPE and VT workload. The mean VT RPE
value was 12.3 ± 1.7, and the mean VT workload was
54.5 ± 17.6. There were no differences in the following var-
iables: age, sex, diseases, body mass index (BMI), and left
ventricular ejection fraction (LVEF) between participants with
or without b-blockers.3.2. Variables significantly affecting the VT RPE scoreTable 3
Effects of b-blockers on the independent parameters and values obtained from
the CPET.
Variable Mean ± SD p
b-blocker No b-blocker
Resting HR (bpm) 73.1 ± 10.9 78.5 ± 11.2 0.02*
HRpeak (bpm) 115.0 ± 14.8 132 ± 17.1 <0.01**
HRpeakerest (bpm) 41.9 ± 14.2 53.5 ± 17.4 <0.01**
VO2max (mL/kg/min) 17.9 ± 4.6 20.3 ± 4.6 0.02*The effects of factors and covariates on VT RPE were
analyzed using multiple lineal regression analysis. The study
results showed that after adjustment for age, sex, diabetes
mellitus, hypertension, New York Heart Association class,
hyperlipidemia, smoking, resting heart rate, ejection fraction
rate, BMI, calcium channel blocker, and antiplatelets, b-
blocker remains statistically significantly associated with VT
RPE (Table 2).Metabolic equivalents
(3.5 mL/kg/min)
5.1 ± 1.3 5.8 ± 1.3 0.01*
VT RPE 12.7 ± 1.7 11.5 ± 1.4 <0.01**
3.3. Effects of b-blockers on the physiological
parametersVT workload (W) 56.7 ± 17.2 51.7 ± 17.9 0.17
RER 1.04 ± 0.1 1.07 ± 0.1 0.05
HRR (bpm) 12.5 ± 8.8 17.0 ± 9.1 0.02*
HR 1 min into the cool-down
phase (bpm)
102.5 ± 12.2 115.1 ± 14.1 <0.01**
Data are presented as mean ± SD.
*p < 0.05.
**p < 0.01.
bpm ¼ beats/min; CPET ¼ cardiopulmonary exercise test; HR ¼ heart rate;
HRR ¼ heart rate recovery; HRpeak ¼ peak heart rate; HRpeakerest ¼ difference
between HRpeak and resting HR; RER ¼ respiratory exchange ratio;
RPE ¼ rating of perceived exertion; SD ¼ standard deviation; VO2max ¼ peak
oxygen consumption; VT ¼ ventilatory threshold.The effects of b-blockers on the physiological parameters
obtained from CPET were analyzed by Student t test and the
details are summarized in Table 3. The mean RER at the end
of exercise was 1.06 ± 0.07. The results of the t test analyses
showed that the resting HR, HRpeak, VO2max, RER, and
metabolic equivalents were lower in the participants taking b-
blockers. The VT RPE was significantly higher (12.7 ± 1.7) in
the participants taking b-blockers compared with those not
taking them (11.4 ± 1.4; Fig. 1). HRR was attenuated in the
participants taking b-blockers (Fig. 2).The HRR did not correlate with LVEF and resting HR.
There was a significant negative correlation between HRR and
age ( p < 0.01). In addition, HRR significantly correlated with
HRpeak and HRpeakerest ( p < 0.01). The relationship between
HRpeakerest and HRR is shown in Fig. 3.
Fig. 1. Effect of b-blockers on the rating of perceived exertion (RPE) values
associated with the ventilatory threshold (VT RPE). *p < 0.05.
Fig. 2. Use of b-blockers attenuates heart rate recovery. *p < 0.05.
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Before entering CR, a symptom-limited CPET is usually
performed. Among the various CPET parameters, the HRmax
and VO2max are typically measured directly in the CPET to
generate guidelines for an individualized exercise prescription.
Through the heart rate-lowering effect of b-blockers, the
interpretation of the heart rate response to exercise based on an
age-predicted maximum heart rate is confounded. As ex-
pected, we found a significantly higher HRpeak in participantsFig. 3. Heart rate recovery correlated significantly with HRpeakerest (R
2 ¼ 0.43,
p < 0.01). HR ¼ heart rate.without b-blockers, which is similar to results reported pre-
viously.7 This lower HRpeak corresponded to a reduced VO2max
in those individuals taking b-blockers.
One important parameter that is used to guide exercise
intensity is the RPE. The role of the RPE in the prescription of
exercise intensity for participants with coronary artery disease
(CAD) is unclear, especially for those taking b-blockers.
Although several studies have discussed the use of the RPE
Scale for exercise prescription, most cohorts were healthy
adults. In participants without an entry exercise test, the rec-
ommended exercise intensity based on the RPE is 11e14. The
Borg 6e20 RPE Scale was designed to assess exertion. In
participants entering CR without an exercise test, the RPE
Scale is also one of the most common methods used to
monitor exercise tolerance.14,21 The correlation between the
RPE and VT is important because the VT is used for the
prescription of exercise intensity.22 Scherr et al23 showed that
in healthy people, the lactate thresholds [either before the
onset of lactate accumulation (LT1) or at a lactate concen-
tration of 1.5mM above LT1] corresponded to RPE values of
10.8 ± 1.8 and 13.6 ± 1.8, respectively. They suggested that
when prescribing exercise intensity, RPE 11e13 is better
suited for more novice participants, whereas RPE 13e15 is
more appropriate for trained participants. In another study on a
cohort of untrained adults, Rynders et al13 showed that RPE
9e12 was correlated with maximal fat oxidation and lactate
threshold, and was thus suggested as the ideal exercise in-
tensity. Our study further clarified the role of RPE in pre-
scribing exercise intensity for patients with a recent episode of
AMI entering CR programs. In this study, an important finding
is that the VT RPE was influenced by the use of b-blockers.
Zanettini et al24 showed that in patients taking b-blockers after
cardiac surgical revascularization, the self-regulation of exer-
cise training intensity between Grade 4 (somewhat hard) and
Grade 5 (hard) of the 10-point category-ratio Borg Scale is
effective but may promote overtraining in some patients
without significant functional advantages. The “somewhat
hard” (Grade 4) exercise training intensity of the 10-point
category-ratio Borg Scale is compatible with Grade 13 of
the 20-point category-ratio Borg Scale. These results suggest
that in patients with a recent episode of AMI and taking b-
blockers, a training intensity of RPE 13 (or RPE 4 of the 10-
point category-ratio Borg Scale) is appropriate. For those with
a recent episode of AMI but not taking b-blockers, RPE 11 is
suggested to be appropriate.
Many clinical trials have shown that b-blockers are
considered a cornerstone therapy in patients with acute coro-
nary syndrome for reducing mortality after AMI.25,26 It is
hypothesized that b-blockers achieve their clinical effects
through their heart rate-lowering capability. Despite a high
rate of the use of b-blockers in outpatients with stable CAD,
patients often have resting HR > 70 beats/min (bpm).27 In our
study, the average resting HR in participants taking b-blockers
was 74.4 bpm. This is consistent with a prior observation
which showed that the average HR was 74 bpm in patients
with postacute coronary syndromes taking b-blockers.28
Although a targeted HR of 50e60 bpm was recommended,29
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Further studies are necessary to validate this therapeutic goal.
HRR is an independent prognostic factor related to overall
mortality associated with cardiovascular diseases,30 and is
thought to be a reflection of vagal tone.31,32 In our study, an
attenuated response of HRR was observed in patients taking b-
blockers. Ushijima et al33 demonstrated that HRR is correlated
with the increment in HR from rest to peak exercise
(HRpeakerest), which was consistent with the result of this
study. As the use of b-blockers attenuated HRpeakerest, this
may explain the attenuated HRR observed in this study.4.1. LimitationsThere were several limitations of this study. First, cycling
was used as the testing instrument in our institution. Compared
with treadmill exercise, the results of exercise tests using a cycle
ergometer yielded a 5e25% lower VO2max.
34 Therefore, it is
unclear whether our findings can be applied to a CR program
using a treadmill or running exercise. Second, this observational
study may not fully reflect regional differences in clinical
characteristics and patterns of care of stable CAD patients, and
the data were collected from a single center that served com-
munities located in central Taiwan. Thus, the data may not
reflect the actual conditions inWestern countries. As theVO2max
obtained in our study was consistent with that reported by Ades
et al35 (who used a treadmill), we think that RPE 11 or 13 can
still provide a valid method for home exercise prescription in
patients with or without b-blocker use. Further clinical in-
vestigations comparing the training effect between different
RPE levels are necessary to support our findings.
In conclusion, the results of this study indicate that in pa-
tients with a recent episode of AMI entering CR programs, the
VO2max is relatively low. It would appear that the prognostic
marker HRR is attenuated by b-blockers. Finally, in patients
who do not undergo a CPET, when using RPE for the initial
exercise prescription to determine training intensity, the use of
b-blockers should be taken into consideration.
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